FYERS
Home
/
Stocks
/
Profit Loss
/
Gland Pharma Profit & Loss

Gland Pharma Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020
₹1800 Cr₹1743 Cr₹1695 Cr₹1487 Cr₹1506 Cr₹1425 Cr₹1384 Cr₹1406 Cr₹1402 Cr₹1537 Cr₹1545 Cr₹1373 Cr₹1209 Cr₹785 Cr₹938 Cr₹1044 Cr₹857 Cr₹1103 Cr₹1063 Cr₹1080 Cr₹1154 Cr₹888 Cr₹859 Cr₹832 Cr₹884 Cr₹635 Cr
₹61 Cr₹111 Cr₹63 Cr₹84 Cr₹58 Cr₹44 Cr₹58 Cr₹60 Cr₹51 Cr₹42 Cr₹37 Cr₹53 Cr₹38 Cr₹39 Cr₹62 Cr₹66 Cr₹74 Cr₹65 Cr₹46 Cr₹51 Cr₹62 Cr₹47 Cr₹35 Cr₹20 Cr₹32 Cr₹46 Cr
₹1862 Cr₹1854 Cr₹1759 Cr₹1571 Cr₹1563 Cr₹1469 Cr₹1443 Cr₹1465 Cr₹1453 Cr₹1580 Cr₹1583 Cr₹1427 Cr₹1246 Cr₹824 Cr₹1000 Cr₹1110 Cr₹931 Cr₹1168 Cr₹1109 Cr₹1132 Cr₹1216 Cr₹935 Cr₹895 Cr₹852 Cr₹916 Cr₹681 Cr
₹1422 Cr₹1338 Cr₹1368 Cr₹1279 Cr₹1239 Cr₹1173 Cr₹1120 Cr₹1203 Cr₹1229 Cr₹1271 Cr₹1294 Cr₹1131 Cr₹980 Cr₹654 Cr₹686 Cr₹784 Cr₹622 Cr₹786 Cr₹742 Cr₹730 Cr₹743 Cr₹585 Cr₹620 Cr₹558 Cr₹496 Cr₹419 Cr
₹551 Cr₹624 Cr₹498 Cr₹398 Cr₹425 Cr₹392 Cr₹418 Cr₹357 Cr₹316 Cr₹401 Cr₹394 Cr₹377 Cr₹331 Cr₹207 Cr₹351 Cr₹362 Cr₹344 Cr₹414 Cr₹395 Cr₹428 Cr₹498 Cr₹375 Cr₹299 Cr₹318 Cr₹445 Cr₹286 Cr
₹4 Cr₹10 Cr₹4 Cr₹8 Cr₹11 Cr₹7 Cr₹23 Cr₹6 Cr₹6 Cr₹10 Cr₹5 Cr₹6 Cr₹5 Cr₹2 Cr₹3 Cr₹2 Cr₹90 L₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹76 L₹47 L₹47 L
₹435 Cr₹506 Cr₹362 Cr₹284 Cr₹313 Cr₹288 Cr₹299 Cr₹257 Cr₹218 Cr₹298 Cr₹283 Cr₹290 Cr₹261 Cr₹111 Cr₹311 Cr₹324 Cr₹308 Cr₹380 Cr₹366 Cr₹401 Cr₹472 Cr₹349 Cr₹273 Cr₹293 Cr₹420 Cr₹262 Cr
₹317 Cr₹367 Cr₹261 Cr₹184 Cr₹215 Cr₹187 Cr₹205 Cr₹164 Cr₹144 Cr₹192 Cr₹192 Cr₹194 Cr₹194 Cr₹79 Cr₹232 Cr₹241 Cr₹229 Cr₹286 Cr₹273 Cr₹302 Cr₹351 Cr₹260 Cr₹204 Cr₹219 Cr₹314 Cr₹195 Cr

Share Price Live Stats

Open (₹)2,915.00
Volume (₹)20.62 L
High (₹)2,940.90
Upper Circuit3,489.40
Low (₹)2,851.10
Lower Circuit2,326.40
Prev Close2,907.90
52W High (₹)3,039.80
Price2,924.90
52W Low (₹)1,573.60

Share Market Cap & Key Ratios Overview

M.Cap (₹)47920.30 Cr
Div. Yield (%)0.69
PE Ratio42.45
Debt to Equity0.02
Price to Book2.71
Book Value625.91
EPS (TTM)68.43
Face Value1.00
ROE (%)10.56

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
GLANDNSE
LTP
1W Low
1W High
Market cap (₹)
1904.8-15.2 (-0.79%)
1902
1984.80
4,56,833Cr
9190-49 (-0.53%)
9087
9467
2,45,426Cr
4901-149 (-2.95%)
4886.50
5066
1,87,320Cr
1133.9-57.1 (-4.79%)
1125.10
1187
1,13,217Cr
1390.6-32.9 (-2.31%)
1376.70
1426.10
1,12,212Cr
1853.5-85 (-4.38%)
1811.70
1949
1,01,155Cr
2126.3-45.2 (-2.08%)
2118.10
2192
97,626Cr
2351.8-31.1 (-1.31%)
2341.20
2419.20
96,859Cr
1164.1-13.9 (-1.18%)
1154.40
1179.90
96,406Cr
1654.3+9 (0.55%)
1622.60
1717
93,614Cr
2924.9+36.9 (1.28%)
2803
2948
47,920Cr

Key Highlights of Gland Pharma Ltd’s P&L

In 2026-03-31, Gland Pharma Ltd reported total revenue of ₹6746.98Cr, compared with ₹5830.11Cr in 2025-03-31, reflecting Gland Pharma Ltd turnover.

Depreciation was ₹423.67Cr and finance costs were ₹33.28Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹1464.58Cr in 2026-03-31 as compared to ₹1062.66Cr in 2025-03-31.

Net Profit (PAT) was ₹1027.32Cr in 2026-03-31 compared with ₹698.53Cr in 2025-03-31.

Earnings per share (EPS) were ₹62.35 in 2026-03-31, compared with ₹42.40 in 2025-03-31.